|
|
||||||||
Department of Pathology, University of Massachusetts Medical School, Worcester, MA 01655
The generation of T cell immunity requires the acquisition and presentation of Ag on bone marrow-derived APCs. Dendritic cells (DC) are believed to be the most potent bone marrow-derived APCs, and the only ones that can stimulate naive T cells to productively respond to Ags. Because macrophages (M
) are bone marrow-derived APCs that are also found in tissues and lymphoid organs, can acquire and present Ag, and can express costimulatory molecules, we have investigated their potential to stimulate primary T cell responses in vivo. We find that both injected M
and DCs can migrate from peripheral tissues or blood into lymphoid organs. Moreover, injection of peptide-pulsed M
or DCs into mice stimulates CD8 T cells to proliferate, express effector functions including cytokine production and cytolysis, and differentiate into long-lived memory cells. M
and DCs stimulate T cells directly without requiring cross-presentation of Ag on host APCs. Therefore, more than one type of bone marrow-derived APC has the potential to prime T cell immunity. In contrast, another bone marrow-derived cell, the T lymphocyte, although capable of presenting Ag and homing to the T cell areas of lymphoid organs, is unable to stimulate primary responses. Because M
can be very abundant cells, especially at sites of infection and inflammation, they have the potential to play an important role in immune surveillance and the initiation of T cell immunity.
This article has been cited by other articles:
![]() |
I. M. Olazabal, N. B. Martin-Cofreces, M. Mittelbrunn, G. Martinez del Hoyo, B. Alarcon, and F. Sanchez-Madrid Activation Outcomes Induced in Naive CD8 T-Cells by Macrophages Primed via "Phagocytic" and Nonphagocytic Pathways Mol. Biol. Cell, February 1, 2008; 19(2): 701 - 710. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Beauvillain, Y. Delneste, M. Scotet, A. Peres, H. Gascan, P. Guermonprez, V. Barnaba, and P. Jeannin Neutrophils efficiently cross-prime naive T cells in vivo Blood, October 15, 2007; 110(8): 2965 - 2973. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, W. Song, D. K. Czerwinski, B. Varghese, S. Uematsu, S. Akira, A. M. Krieg, and R. Levy Lymphoma Immunotherapy with CpG Oligodeoxynucleotides Requires TLR9 Either in the Host or in the Tumor Itself J. Immunol., August 15, 2007; 179(4): 2493 - 2500. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Takenaka, E. Safroneeva, Z. Xing, and J. Gauldie Dendritic Cells Derived from Murine Colonic Mucosa Have Unique Functional and Phenotypic Characteristics J. Immunol., June 15, 2007; 178(12): 7984 - 7993. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Thomas, G. A. Kolumam, and K. Murali-Krishna Antigen Presentation by Nonhemopoietic Cells Amplifies Clonal Expansion of Effector CD8 T Cells in a Pathogen-Specific Manner J. Immunol., May 1, 2007; 178(9): 5802 - 5811. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Burgdorf, A. Kautz, V. Bohnert, P. A. Knolle, and C. Kurts Distinct Pathways of Antigen Uptake and Intracellular Routing in CD4 and CD8 T Cell Activation Science, April 27, 2007; 316(5824): 612 - 616. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. H. Hernandez, L. Shen, and K. L. Rock CD40-CD40 Ligand Interaction between Dendritic Cells and CD8+ T Cells Is Needed to Stimulate Maximal T Cell Responses in the Absence of CD4+ T Cell Help J. Immunol., March 1, 2007; 178(5): 2844 - 2852. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Ciavarra, A. Stephens, S. Nagy, M. Sekellick, and C. Steel Evaluation of Immunological Paradigms in a Virus Model: Are Dendritic Cells Critical for Antiviral Immunity and Viral Clearance? J. Immunol., July 1, 2006; 177(1): 492 - 500. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |